International Stroke Trial "IST"

Completed

Phase 3 Results

Results

There was no statistically significant difference in death at 14 days, or death or dependence at 6 months between patients receiving heparin vs. no heparin. There was, however, a statistically significant difference in the number of deaths and recurrent strokes between patients receiving aspirin vs. no aspirin after adjustment for baseline prognosis.